Quantcast Hard To Treat Diseases Inc. HTDS Targets An EU Based Stem Cell Research Company - Congoo
 
 
PHARMACEUTICAL INDUSTRY Log In
Hard to Treat Diseases Inc. HTDS Targets an EU Based Stem Cell Research Company
Have an interest in this Story?
Sign Up for Real-Time email updates
Pharmacy Choice  | November 07, 2009

- (NewsRx.com) Hard to Treat Diseases (HTDS; http://www.htdsmedical.com/) and its operating subsidiary Slavica Bio Chem, announces that it is targeting an EU based company, and has initiated talks that may involve a merger (see also Hard to Treat Diseases). Hard to Treat Diseases Inc. (HTDS) and the...
Read Full Article   
 
Leave a Comment: You must be logged in to leave a comment     Log in | Register
 

Featured Members
Mark Palmer Mark Palmer
Founder
Internet consultancies
Matthew Clark Matthew Clark
Mentor
Entrepreneur

  
  View more profiles

 
Access dozens of premium and subscriptions sites Free! Download now.

Advertise   |   Build a News Circle   |   Get News Briefings   |   Congoo News Home   |   Get the Netpass
About Congoo   |   Terms   |   Privacy   |   Need Help?   |   Site Map
Copyright ©2009 Congoo.com. All Rights Reserved.